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Abstract
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This study aimed to identify the variables that influence parental treatment decisions after a
prenatal diagnosis of congenital heart disease (CHD). The authors reviewed all cases of prenatally
diagnosed structural CHD from August 1998 to December 2006 at their center. The following
variables were studied as potential predictors of parental intent to treat: maternal age, race,
insurance status, obstetric history, fetal gender, univentricular versus biventricular cardiac
physiology, and fetal chromosomal abnormality. Uni- and multivariable logistic regression
analyses were performed. In the review, 252 consecutive cases of prenatally diagnosed CHD were
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identified. Of these, 204 women pursued full medical treatment, whereas 25 women sought
termination of pregnancy or comfort care. Parental intent to treat was unknown for 23 cases.
Multivariable logistic regression analysis identified fetal chromosomal abnormality as the only
variable that influenced parental intent to treat (odds ratio [OR], 14.33; 95% confidence interval
[CI], 3.28–62.66; p = 0.0006). An associated chromosomal abnormality rather than the severity of
the heart defect influences the decision to choose termination of pregnancy or comfort care for a
fetus with prenatally diagnosed CHD. Women were 14 times more likely to terminate a pregnancy
or seek comfort care for a fetus with CHD if a chromosomal abnormality was present.
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Fetal echocardiography is widely described as a reliable diagnostic tool [2, 7, 16, 17].
Advances in fetal echocardiography have allowed for earlier and more accurate detection of
complex cardiac abnormalities. As a result, when congenital heart disease (CHD) is
suspected in a fetus, the obstetrician and pediatric cardiologist play an influential role in the
prenatal counseling and perinatal planning, a role that will increase as fetal
echocardiography continues to become more widely used.
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A prenatal diagnosis of CHD is stressful information for parents that generates many
difficult questions including the emotive issues of pregnancy termination and comfort care
[2, 4, 17, 19]. The roles of the obstetrician and pediatric cardiologist are to provide an
accurate diagnosis of the malformation, a clear and truthful picture of the prognosis, an
outline of the management and treatment options available, and assistance to parents in
reaching the form of management that is best for them [1].

Author Manuscript

Currently, a sizable body of literature exists that examines the accuracy of fetal
echocardiography and its impact on the preoperative condition of the infant and the surgical
outcomes [5, 8, 9, 19, 23]. It also is well described that many infants with CHD have
extracardiac abnormalities such as visceral heterotaxy and chromosomal defects [4, 7, 11,
16–18]. Termination of pregnancy is reported in the existing literature and, depending on the
setting, termination rates among prenatally diagnosed cases of CHD range from 8% to 60%
[4, 7, 16, 17, 23]. However, little research has aimed to identify the maternal and fetal
factors that have an impact on parental treatment decisions after the prenatal diagnosis of
CHD. Effective and thorough prenatal counseling includes an understanding of the issues
that influence parental treatment decisions. Therefore, we sought to determine which factors
influence parental treatment decisions for a fetus with prenatally diagnosed CHD referred to
a regional surgical center.

Materials and Methods
The study population consisted of pregnant women referred to the Medical University of
South Carolina (MUSC) for a fetal echocardiogram between August 1998 and December
2006. The Children’s Heart Program of South Carolina based at MUSC in Charleston serves
the entire state with four centers located respectively in Charleston, Columbia, Greenville,
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and Florence. Since August 1998, the vast majority of fetuses in South Carolina with
prenatally diagnosed critical CHD have been referred to MUSC for prenatal evaluation,
delivery, and postnatal management.
Critical congenital heart disease was defined as any cardiac structural defect that could
potentially require surgical intervention in the first year of life. All patients given a prenatal
diagnosis of critical CHD between August 1998 and December 2006 were included in the
study. Patients with a prenatal diagnosis of nonstructural heart disease (i.e., fetal arrhythmia)
or structural heart disease not requiring surgical intervention in the first year of life were
excluded from the study.
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A retrospective chart review was performed for all patients undergoing a fetal
echocardiogram at MUSC between August 1998 and December 2006. The study received
institutional review board approval from MUSC.
The study participants were categorized into two outcome groups: the intent-to-treat group
and the intent-not-to-treat group. Intent not to treat was defined as the parental decision to
seek termination of pregnancy or comfort care.
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The maternal and fetal characteristics of the study patients in both outcome groups were
reviewed (Table 1). Fetal characteristics examined for potential association with parental
treatment intention (to treat or not treat) included gender, chromosomal abnormality
confirmed by amniocentesis and/or postnatal testing, and ventricular cardiac physiology
(uni- or biventricle). Maternal characteristics included maternal age (years), gravida (1 vs 2
or more), parity (0 vs 1 or more), race (white, black, or other), and insurance status (private
vs Medicaid). All patients were insured, and the status “private” included commercial
groups, health maintenance organizations, and military insurance. Insurance status was used
to classify the socioeconomic group, with Medicaid as a surrogate marker of lower
socioeconomic class. Maternal age was treated as a continuous variable in all the analyses,
whereas all other variables were treated as categorical variables.
Bivariable associations between maternal and fetal characteristics and parental treatment
intention were assessed using Fisher’s exact test for categorical variables and the Wilcoxon
rank-sum test for continuous predictors. In addition, univariable logistic regression models
with treatment intention as the outcome variable were fitted for each covariate to obtain
estimates of unadjusted odds ratios.
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Due to patterns of missing data among the covariates, a multivariable regression model
based on a complete case analysis substantially reduced the number of intent-not-totreat
subjects available for analysis. Therefore, to accommodate multivariable modeling, a
multiple imputation model was used to augment missing covariate data with a sequence of
Gibbs sampler iterations, as described by van Buuren [20, 21]. Multiple imputation has been
shown to produce efficient and unbiased estimates if the data are missing at random [14, 15].
Specifically, the missing quality of being was assumed to be associated possibly with other
observed variables but not with the value of the partially observed variable itself.
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In our data, missing covariate information was primarily attributable to incomplete medical
records, thus satisfying the missing at random assumption. Multivariable models were
constructed from the imputation data sets using multiple logistic regression analysis. The
fitted models were used to identify independent factors associated with parental intention
not to treat. Odds ratio (OR) estimates were obtained as the average across regressions, with
corresponding interval estimates reflecting both within-and between-imputation variability.
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The number of logistic regression model covariates was limited by the total number of
events (subjects with intention not to treat) in the study [12]. Due to the small number of
events in this analysis (total of 25), only those maternal and fetal characteristics with
attained significance close to nominal α of 0.05 were considered for inclusion in the
multivariable model. The functional form of continuous variables was assessed using the
method of fractional polynomials [6, 13]. Model fit was assessed on the basis of both the
Hosmer and Lemeshow’s goodness-of-fit test and the area under the receiving operator
characteristic curve.
All statistical tests were two-sided, and type 1 error was controlled for each test at a level of
0.05. Analyses were performed with SAS (version 9.1; SAS Institute, Inc., Cary, NC, USA).
Multiply imputed data sets were generated using R (R Development Core Team, R
Foundation for Statistical Computing, Vienna, Austria, 2007).

Results

Author Manuscript

Between August 1998 and December 2006, 252 cases of prenatally diagnosed critical CHD
were identified. After 14 pregnancies (5%) ended in fetal demise and 9 families (4%) were
lost to follow-up evaluation, 229 subjects were available for the current analysis. Of these
229 subjects, 204 (89%) elected to treat, and 25 (11%) elected not to treat. Among the 25
families that elected not to treat, 14 chose termination of pregnancy and 11 chose comfort
care (Fig. 1).
Table 1 summarizes the associations between fetal and maternal characteristics and parental
treatment intention. The fetal characteristics that demonstrated a significant difference
between the treatment intention groups were chromosomal abnormality (p < 0.0001) and
biventricular physiology (p = 0.005). The maternal characteristics that demonstrated a
significant difference between the treatment intention groups were maternal gravida status (p
= 0.047) and age (p = 0.005). Maternal insurance status approached demonstration of a
significant difference between the treatment intention groups (p = 0.055).
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Table 2 summarizes the results of the multiple logistic regression modeling for the 15
multiply imputed data sets. Multivariable analyses showed only chromosomal abnormality
to be associated independently with parental treatment preference (OR, 14.33; 95%
confidence interval [CI], 3.28–62.66; p = 0.0006). Once a prenatal diagnosis of critical CHD
was made, a 14-fold increase in the odds of choosing not to treat was observed when a
chromosomal abnormality was present.
The following variables for inclusion in the model were considered: chromosomal
abnormality, ventricular physiology, maternal age, insurance status, and gravida. Even with
Pediatr Cardiol. Author manuscript; available in PMC 2015 March 11.
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the imputed data, the number of subjects with intention not to treat was small (total of 25
events), resulting in a rate of 5 events per variable in the final 5-variable model. This low
event rate precluded investigation of variable interactions and additional assessment of
confounding by the remaining fetal and maternal characteristics. The Hosmer and
Lemeshow goodness-of-fit test indicated an adequate fit for the multiple logistic regression
models fitted to the 15 multiply imputed data sets. Additionally, the average area under the
receiving operating characteristic curve across the 15 models was 0.88 (range, 0.85–0.90),
indicating that the models’ ability to predict treatment preference was good. Some evidence
of nonlinearity in maternal age was detected, so the method of fractional polynomials was
used to identify optimal transformations [6, 13]. However, maternal age was modeled
linearly because no model with transformed age provided a statistically significant
improvement in fit.

Author Manuscript

After chromosomal abnormality was identified as a significant predictor of the parental
intent not to treat, the amniocentesis and postnatal chromosome results for the 25 families
that chose termination of pregnancy or comfort care were reviewed (Fig. 2). Of the 18 cases
with abnormal chromosome results, 16 had a prenatal diagnosis using amniocentesis and
two had a postnatal diagnosis.
Among the 14 families that chose termination of pregnancy, 1 had normal amniocentesis
results, 10 had abnormal amniocentesis results, and 3 had unknown results because
amniocentesis was not performed. Of the abnormal amniocentesis results in the termination
group, eight were Trisomy 21, one was Trisomy 18, and one was a complex abnormality
with multiple chromosome foci involvement.
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Among the 11 families that chose comfort care, 2 were cases of normal chromosomes, 6
were cases of chromosomal abnormality diagnosed prenatally by amniocentesis, 2 were
cases of chromosomal abnormality diagnosed postnatally, and 1 case was unknown. Of the
abnormal amniocentesis results in the comfort care group, two were Trisomy 13, two were
Trisomy 18, one was a partial Trisomy 14, and one was an unbalanced translocation. Both
families with normal chromosome results in the comfort care group had fetuses with severe
multiorgan abnormalities. One of these pregnancies had conjoined twinning.

Discussion

Author Manuscript

Counseling parents after a prenatal diagnosis of CHD is an important task for the
obstetrician and pediatric cardiologist. In most circumstances, the role of the pediatric
cardiologist during the prenatal period is to provide information rather than treatment. The
pediatric cardiologist is faced with the challenge of effectively communicating accurate
cardiac anatomic details, the need for intervention, and the likely outcomes so that parents
are enabled to make fully informed treatment decisions [1, 11].
In the population studied, an associated chromosomal abnormality rather than the severity of
the heart defect influenced the decision to choose termination of pregnancy or comfort care
for a fetus with prenatally diagnosed CHD. Interestingly, single-ventricle physiology did not
affect parental treatment plans. Instead, in the univariable analysis, two-ventricle physiology
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was a predictor of the parental decision not to treat. This relationship is most likely due to
the confounding effects of Trisomy 21 because most patients with Trisomy 21 have twoventricle heart disease. The majority of fetuses that were terminated had heart lesions that
ordinarily have good surgical outcomes (i.e., atrioventricular septal defect, atrial septal
defect, and ventricular septal defect), supporting the observation that chromosomal
abnormalities were an important issue for some parents, influencing their treatment
decisions.
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Early detection of fetal chromosomal abnormalities has several major advantages. First, in
the cases with severe heart disease in which the postnatal outcome is expected to be poor,
parents may use the data in considering termination of pregnancy. Second, in the cases
involving parents who wish to continue with the pregnancy, advanced knowledge of a
chromosomal defect allows time for mental and emotional preparation. Parents may enter
the postnatal period better equipped to use the multidisciplinary services that a child with a
chromosomal defect typically requires. In addition, early knowledge of any chromosomal
abnormalities allows the pediatric cardiologist to provide more accurate information
regarding the long-term outcomes. This is particularly applicable for infants whose
concomitant diagnosis of certain structural heart disease and chromosome abnormality
associates them with increased morbidity and mortality [3, 10]. If the diagnosis is
determined prenatally, arrangements can be made for these high-risk infants to be delivered
at a tertiary care center where pediatric cardiology and cardiac surgery is immediately
available. A prenatally detected chromosomal abnormality also enables the pediatric
cardiologist to prepare the parents better for possible miscarriage or preterm delivery if there
is an increased risk.
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Among the 14 families that chose termination of pregnancy, 8 had a prenatal diagnosis of
Trisomy 21. It is interesting to note that among the 12 cases of 22q11 deletion, none of the
families elected termination of pregnancy or comfort care. However, without knowing the
specific details of the prenatal counseling sessions, it is not possible to determine why such
decisions were made.
The impact of gestational age at the time of diagnosis could not be included in our statistical
analysis because many of the mothers had received a preliminary diagnosis at an earlier
gestational age by their local obstetrician or cardiologist. Referrals to our institution for
confirmatory diagnosis and establishment of tertiary care often occurred after 24 weeks
gestation. The mean gestational age at diagnosis was 27.6 weeks. It is unclear whether the
late referrals reflected a parent’s decision to decline termination of pregnancy or whether the
cardiac anomaly simply was not detected until a later gestational age.
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This study had several limitations. It was a retrospective, single-center study. The
characteristics of this study population may have been specific to our medical center and not
representative of the larger national or international population. Because the population in
South Carolina is predominantly conservative socially and politically, the study subjects
may have been more likely to decline termination of pregnancy than patients at other
centers. Some potentially important variables such as gestational age at the time of the initial
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diagnosis, religion, marital status, and whether the pregnancy was planned were not
available for analysis.
The potential bias introduced during counseling was not included because it could not be
measured retrospectively. Furthermore, many of our patients received counseling from
several different individuals (primary obstetrician, high-risk obstetrician, geneticist, and
pediatric cardiologist), making it difficult to assess the influence of one individual counselor
accurately. Although late referrals and diagnosis can limit the number of terminated
pregnancies, it should not have limited the number of cases of comfort and palliative care.
A small possibility exists that false-positive prenatal chromosome analysis may have
resulted in termination. However, the likelihood of this occurring is low given that the
reported accuracy of amniocentesis and chorionic villus sampling exceeds 99% [22].

Author Manuscript

In conclusion, fetal chromosomal abnormality appears to be an important issue for parents
after they have received a prenatal diagnosis of CHD. In this study, an associated
chromosomal abnormality was more likely to result in termination of pregnancy or in
comfort care than the severity of the structural heart defect. Approximately 60% of the
families that chose termination of pregnancy had a fetus with a prenatal diagnosis of
Trisomy 21. Amniocentesis serves an important role of facilitating informed parental
decisions after a prenatal diagnosis of CHD and should be offered to every family in the
prenatal counseling session. Additionally, follow-up counseling after the amniocentesis is
necessary to ensure that parents are appropriately and accurately informed about the
abnormalities and anticipated outcomes.
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Parental treatment intention in 252 consecutive cases of prenatally diagnosed critical
congenital heart disease between August 1998 and December 2006
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Fig. 2.

Amniocentesis and postnatal chromosome results for 229 cases of prenatally diagnosed
critical congenital heart disease in which parental treatment intention was identified. amnio
amniocentesis, postnatal postnatal chromosome testing, TOP termination of pregnancy
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Summary of bivariable associations between fetal and maternal characteristics and parental treatment intention
Variable

Level

Treatment intentiona
Not treat (n = 25)

p valueb

Treat (n = 204)

Fetal characteristics
Gender

0.80
Male

10 (8)

122 (92)

Female

8 (9)

81 (91)

No

3 (2)

135 (98)

Yes

18 (33)

36 (67)

Chromosomal abnormality

<0.0001

Ventricular physiology

0.0047

Author Manuscript

Univentricular

4 (4)

108 (96)

Biventricular

16 (15)

94 (85)

Maternal characteristics
Race

0.63
Caucasian

14 (10)

121 (90)

African-American

7 (10)

62 (90)

Other

4 (17)

20 (83)

Insurance

0.055
Medicaid

8 (7)

108 (93)

17 (15)

93 (85)

1

1 (2)

52 (98)

2+

17 (12)

127 (88)

Private
Gravida

0.047

Author Manuscript

Parity

Age (years)c

0.62
0

6 (7)

76 (93)

1+

12 (10)

103 (90)

31 (27–37)

27 (22–33)

0.0051

a
Values for categorical variables are frequencies (%). Values reported for age are median (interquartile range) due to skewness in the distribution
of maternal age. Some frequencies summed across levels of categorical variables do not total 25 for intention not to treat and 204 for intention to
treat due to missing values
b

p values for categorical variables were calculated using Fisher’s exact test; p value for age was calculated using the Wilcoxon rank-sum test

c

Seven intent-to-treat subjects had missing values for maternal age
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Summary of univariable (unadjusted) and multivariable (adjusted) logistic regression analyses
Variable

Unadjusteda

Adjustedb

OR (95% CI)

p value

OR (95% CI)

p value

Chromosomal abnormality

22.49 (6.28, 80.59)

<0.0001

14.33 (3.28, 62.66)

0.0006

Biventricle physiology

4.60 (1.49, 14.23)

0.0082

1.56 (0.41, 5.93)

0.51

Maternal agec

1.47 (1.11, 1.96)

0.0075

1.09 (0.74, 1.62)

0.65

Gravida 2+

6.96 (0.90, 53.64)

0.063

1.28 (0.37, 1.40)

0.28

Private insurance

2.47 (1.02, 5.99)

0.045

2.01 (0.64, 6.34)

0.23

OR odds ratio, CI confidence interval
a

Univariable logistic regression models were fitted based on a complete case analysis of the original data
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b

Multivariable logistic regression analysis was based on 15 data sets, with missing data multiply imputed. OR and corresponding 95% CI reflect
both within- and between-imputation variability
c

Odds ratio for maternal age is for a 5-year increase
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